Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C

Cardiovascular Research

Volumn 43, Issue 4, 1999, Pages 1018-1028

  Ungvari, Zoltan ^a   Pacher, Pal ^a   Kecskemeti, Valeria ^a   Papp, György ^a   Szollár, Lajos ^a   Koller, Akos ^a  

^a Pharmacol Dept Urol S   (United States)

Author keywords

Calcium channels; Calcium sensitivity; Diabetes mellitus; Intraluminal pressure; Microcirculation; Protein kinase C; Rat

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL; NORADRENALIN; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANALYSIS OF VARIANCE; ANIMALS; ARTERIOLES; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; MALE; MICROSCOPY, VIDEO; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITROARGININE; NOREPINEPHRINE; PROTEIN KINASE C; RATS; RATS, WISTAR; TETRADECANOYLPHORBOL ACETATE; VASOCONSTRICTOR AGENTS;

EID: 0032846804     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00106-6     Document Type: Article

References (48)

1. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease: the Framingham Study. J Am Med Assoc. 241:1979;2035-2038.
2. Garcia M.J., McNamara P.M., Gordon T., Kannel W.B. Diabetes as a cardiovascular risk factor. Diabetes. 23:1974;105-112.
3. Ruderman N.B., Gupta S., Sussman I. An overview. Ruderman N.B., Williamson J.R., Brownlee M.L. Hyperglycemia, diabetes, and vascular disease. 1992;3-20 Oxford Press, New York, NY.
4. Hill M.A., Larkins R.G. Alterations in distribution of cardiac output in experimental diabetes. Am J Physiol. 257:1989;H571-H580.
5. Hill M.A., Meininger G.A., Granger H.J. Altered skeletal muscle hemodynamics after one week of streptozotocin induced diabetes. Microcirc Endothelium Lymphatics. 2:1985;687-704.
6. Tooke J.E. Microvascular function in human diabetes. Diabetes. 44:1995;721-726.
7. Johnson P.C. The myogenic response. Handbook of physiology. The cardiovascular system. Vascular smooth muscle. II:1980;409-442 Am. Physiol. Soc, Bethesda, MD. sect 2, chap. 15.
8. Sun D., Kaley G., Koller A. Characteristics and origin of myogenic response in isolated gracilis muscle arterioles. Am J Physiol. 266:1994;H1177-H1183.
9. Hill M.A., Meininger G.A. Impaired arteriolar myogenic reactivity in early experimental diabetes. Diabetes. 42:1993;1226-1232.
10. Hill M.A., Ege E.A. Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effect of aminoguanidine treatment. Diabetes. 432:1994;1450-1456.
11. Huang A., Sun D., Koller A. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension. Hypertension. 22:1993;913-921.
12. Tribe R.M., Thomas C.R., Poston L. Flow-induced dilation in isolated resistance arteries from control and streptozotocin-diabetic rats. Diabetologia. 41:1998;34-39.
13. Alsip N.L., Schuschke D.A., Miller F.N. Microvascular responses in the skeletal muscle of the diabetic rat. J Lab Clin Med. 128:1996;429-437.
14. De Tejada I.S., Goldstein I., Azadzoi K., Krane R.J., Cohen R.A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Eng J Med. 320:1989;1025-1030.
15. McNally P.G., Watt P.A.C., Rimmer T., et al. Impaired contraction and endothelium-dependent relaxation in isolated resistance vessles from patients with insulin dependent diabetes mellitus. Clin Sci. 87:1994;31-36.
16. Diederich D., Skopec J., Diederich A., Dai F.X. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats role of free radicals. Am J Physiol. 266:1994;H1153-H1161.
17. Mayhan W.G. Impairment of endothelium dependent dilation of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 256:1989;H621-H625.
18. Taylor P.D., Graves J.E., Poston L. Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic rat. Clin Sci Colch. 88:1995;519-524.
19. + channel openers in cerebral arteries from diabetic rats. Circ Res. 81:1997;996-1004.
20. Hill M.A., Falcone J.C., Meininger G.A. Evidence for protein kinase C involvement in arteriolar myogenic reactivity. Am J Physiol. 259:1990;H1586-H1594.
21. Huang A, Sun D, Koller A, Kaley G. Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am J Physiol (Heart Circ Physiol 41);1997:H1804-H1809.
22. Huang A, Sun D, Koller A, Kaley G. Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am J Physiol (Heart Circ Physiol 41);1997:H1804-H1809.
23. Huang A., Sun D., Kaley G., Koller A. Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension. 29:1997;1351-1356.
24. White R.E., Carrier G.O. Enhanced vascular α-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol. 255:1988;H1036-H1042.
25. Inazu M., Sakai Y., Homma I. Contractile responses and calcium mobilization in renal arteries of diabetic rats. Eur J Pharmacol. 203:1991;79-84.
26. Tam S.L., Ferguson D.G., Bielefeld D.R., et al. Norepinephrine-mediated calcium signaling is altered in vascular smooth muscle of diabetic rat. Cell Calcium. 21:1997;143-150.
27. Sipkema P., Westerhof N., Hoogerwerf N. Rate of the myogenic response increases with the constriction level in rabbit femoral arteries. Ann Biomed Eng. 25:1997;278-285.
28. Pieper M.G., Gross G.J. Endothelial dysfunction in diabetes. Rubanyi G.M. Cardiovascular significance of endothelium-derived vasoactive factors. 1991;225-249 Futura, New York.
29. Arbogast B.W., Berry D.L., Newell C.L. Injury of arterial endothelial cells in diabetic sucrose-fed and aged rats. Atherosclerosis. 51:1984;31-45.
30. Endo K., Abiru T., Machida H., Kasuya Y., Kamata K. Endothelium derived hyperpolarizing factor does not contribute to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic rats. Gen Pharmacol. 26:1995;149-153.
31. Kamata K., Miyata N., Kasuya Y. Impairment of endothelium-dependent relaxation and changes in levels of cGMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol. 97:1989;614-618.
32. Cohen R.A. Dysfunction of the vascular endothelium in diabetes mellitus. Circ. 87:1993;V67-V76.
33. Taylor P.D., McCarthy A.L., Thomas C.R., Poston L. Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocine-induced diabetic rats. Br J Pharmacol. 107:1992;393-399.
34. Chang K.S.K., Stevens W.C. Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br J Pharmacol. 107:1992;983-990.
35. Savage M.W., Bodmer C.W., Walker A.B., et al. Vascular reactivity to noradrenaline and neuropeptide Y in the streptozotocin-induced diabetic rat. Eur J Clin Invest. 25:1995;974-979.
36. White R.E., Carrier G.O. Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J Pharmacol Exp Ther. 253:1990;1057-1063.
37. Kaley G., Koller A., Rodenburg J.M., Messina E.J., Wolin M.S. Regulation of arteriolar tone and responses via L-arginine pathway in skeletal muscle. Am J Physiol. 262:1992;H987-992.
38. Harris K.H., MacLeod K.M. Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol. 153:1988;55-64.
39. Devendra K.A., McNeill J.H. Vascular responses to agonists in rat mesenteric arteries from diabetic rats. Can J Physiol Pharmacol. 65:1986;1484-1490.
40. Agrawal D.K., McNeill J.H. Vascular responses to agonists in rat mesenteric artery from diabetic rats. Can J Physiol Pharmacol. 65:1987;1484-1490.
41. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes. 47:1998;859-866.
42. 2+ channels associated with protein kinase C activity. J Vasc Res. 32:1995;220-229.
43. Ishii H., Jirousek M.R., Koya D., Takagi C., et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science. 272:1996;728-731.
44. 2+ and protein kinase C in developing myogenic contraction in isolated rat small arteries. Am J Physiol. 272:1997;H1165-117.
45. D'Angelo G., Davis M.J., Meininger G.A. Calcium and mechanotransduction of the myogenic response. Am J Physiol. 42:1997;H175-H182.
46. 2+ concentration, or 20-kDa myosin light chain phosphorylation. J Mol Cell Cardiol. 26:1994;297-302.
47. Osol G., Laher I., Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from cerebral circulation. Circ Res. 68:1991;359-367.
48. Hill M.A., Meininger G.A. Calcium entry and myogenic phenomena in skeletal muscle arterioles. Am J Physiol. 67:1994;H1085-H1092.